RIO DE JANEIRO, BRAZIL - With the arrival of two million doses of AstraZeneca's Covid-19 vaccine manufactured in India, and the emergency use authorization of another 4.8 million doses of the Coronavac by ANVISA (National Health Regulatory Agency), Brazil has doubled the amount of available vaccines and boosted this first stage of the immunization campaign. There are 12.8 million doses already authorized for use by the health regulator, including those distributed among states this week.
Administered in two doses as determined by the manufacturer, the available immunizers will only be sufficient to immunize a little over six . . .